NEW YORK (GenomeWeb News) – Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer has acquired a site license for two bioinformatics software programs from BioDiscovery.
The El Segundo, Calif.-based bioinformatics firm said that the Keystone Program will use the firm's Nexus Copy Number and Nexus Expression tools for DNA copy number and RNA expression analysis from microarray data.
"The Nexus Suite enables us to be less dependent on in-house bioinformatics support as we attempt to identify the subset of genes regulating development and transformation from among the larger cohort whose altered expression or copy-number is merely correlated with these processes," David Wiest, co-leader of the Keystone Program, said in a statement.
BioDiscovery noted that the two software products support all array platforms including Agilent, Affymetrix, Illumina, Roche NimbleGen, and custom arrays. It said the tools can integrate data from thousands of arrays in a single project and provide a streamlined interface for data exploration.